Guidelines on the use of therapeutic apheresis in clinical practice–evidence‐based approach from the Writing Committee of the American Society for Apheresis: the eighth special … A Padmanabhan, L Connelly‐Smith, N Aqui, RA Balogun, R Klingel, ... Journal of clinical apheresis 34 (3), 171-354, 2019 | 1250 | 2019 |
Guidelines on the use of therapeutic apheresis in clinical practice–evidence‐based approach from the writing committee of the American society for apheresis: the seventh … J Schwartz, A Padmanabhan, N Aqui, RA Balogun, L Connelly‐Smith, ... Journal of clinical apheresis 31 (3), 149-338, 2016 | 1079 | 2016 |
Transfusion reactions: prevention, diagnosis, and treatment M Delaney, S Wendel, RS Bercovitz, J Cid, C Cohn, NM Dunbar, ... The Lancet 388 (10061), 2825-2836, 2016 | 529 | 2016 |
TRANSFUSION PRACTICE: Thrombin generation in trauma patients NM Dunbar, WL Chandler Transfusion 49 (12), 2652-2660, 2009 | 261 | 2009 |
Guidelines on the Use of therapeutic apheresis in clinical practice–Evidence‐Based approach from the Writing Committee of the American Society for Apheresis: The Ninth Special … L Connelly‐Smith, CR Alquist, NA Aqui, JC Hofmann, R Klingel, ... Journal of clinical apheresis 38 (2), 77-278, 2023 | 173 | 2023 |
Transfusion guidelines: when to transfuse ZM Szczepiorkowski, NM Dunbar Hematology 2013, the American Society of Hematology Education Program Book …, 2013 | 146 | 2013 |
International validation of a dithiothreitol (DTT)‐based method to resolve the daratumumab interference with blood compatibility testing CI Chapuy, MD Aguad, RT Nicholson, JP AuBuchon, CS Cohn, ... Transfusion 56 (12), 2964-2972, 2016 | 121 | 2016 |
Safety of the use of group A plasma in trauma: the STAT study NM Dunbar, MH Yazer, ... Transfusion 57 (8), 1879-1884, 2017 | 100 | 2017 |
Combination of peritubular c4d and transplant glomerulopathy predicts late renal allograft failure N Kieran, X Wang, J Perkins, C Davis, E Kendrick, R Bakthavatsalam, ... Journal of the American Society of Nephrology 20 (10), 2260-2268, 2009 | 85 | 2009 |
ABO incompatible platelets: risks versus benefit NM Dunbar, DL Ornstein, LJ Dumont Current opinion in hematology 19 (6), 475-479, 2012 | 78 | 2012 |
It is time to reconsider the risks of transfusing RhD negative females of childbearing potential with RhD positive red blood cells in bleeding emergencies MH Yazer, M Delaney, H Doughty, NM Dunbar, AZ Al-Riyami, DJ Triulzi, ... Transfusion 59 (12), 3794-3799, 2019 | 71 | 2019 |
Safety and efficacy of cryopreserved platelets in bleeding patients with thrombocytopenia SJ Slichter, LJ Dumont, JA Cancelas, ML Jones, TB Gernsheimer, ... Transfusion 58 (9), 2129-2138, 2018 | 68 | 2018 |
Safety of platelet transfusion: past, present and future MC Katus, ZM Szczepiorkowski, LJ Dumont, NM Dunbar Vox sanguinis 107 (2), 103-113, 2014 | 62 | 2014 |
Necrotizing fasciitis: manifestations, microbiology and connection with black tar heroin NM Dunbar, RC Harruff Journal of forensic sciences 52 (4), 920-923, 2007 | 59 | 2007 |
Electronic patient identification for sample labeling reduces wrong blood in tube errors RM Kaufman, A Dinh, CS Cohn, MK Fung, J Gorlin, S Melanson, ... Transfusion 59 (3), 972-980, 2019 | 58 | 2019 |
Significant reduction in red blood cell transfusions in a general hospital after successful implementation of a restrictive transfusion policy supported by prospective … S Yerrabothala, KP Desrosiers, ZM Szczepiorkowski, NM Dunbar Transfusion 54 (10pt2), 2640-2645, 2014 | 54 | 2014 |
COVID‐19 convalescent plasma: interim recommendations from the AABB CS Cohn, L Estcourt, BJ Grossman, MB Pagano, ES Allen, EM Bloch, ... Transfusion 61 (4), 1313, 2021 | 50 | 2021 |
Blood group antigen matching influence on gestational outcomes (AMIGO) study M Delaney, A Wikman, L van de Watering, H Schonewille, JP Verdoes, ... Transfusion 57 (3), 525-532, 2017 | 49 | 2017 |
Survey of group A plasma and low‐titer group O whole blood use in trauma resuscitation at adult civilian level 1 trauma centers in the US MH Yazer, PC Spinella, V Anto, NM Dunbar Transfusion 61 (6), 1757-1763, 2021 | 48 | 2021 |
Ibrutinib is an effective treatment of autoimmune haemolytic anaemia in chronic lymphocytic leukaemia. S Manda, N Dunbar, CR Marx‐Wood, AV Danilov British Journal of Haematology 170 (5), 2015 | 48 | 2015 |